Tfmpp Stats & Data
Psychoactive Class
Stimulant
Pharmacology
DrugBankMetabolism
1-(3-Trifluoromethylphenyl)piperazine has known human metabolites that include HO-TFMPP.
Effect Profile
Curated + 19 Reports
Stimulant
6.5
Strong euphoria and anxiety/jitters with moderate focus and stimulation
Stimulation / Energy×3
6
Euphoria / Mood Lift×2
10
Focus / Productivity×2
7
Anxiety / Jitters×1
10
Based on reports from:
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1d
Half tolerance
10d
Baseline
~18d
Experience Report Analysis
Erowid
19
Reports
1999–2008
Date Range
12
Effects Detected
Demographics
Gender Distribution
Reports Over Time
Effect Analysis
ErowidEffects aggregated from 19 experience reports (19 Erowid)
19
Reports
12
Effects Detected
6
Positive
4
Adverse
2
Neutral
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 6
Stimulation
57.9%
70%
Empathy
52.6%
70%
Euphoria
47.4%
70%
Music Enhancement
36.8%
70%
Color Enhancement
26.3%
70%
Tactile Enhancement
26.3%
70%
Adverse Effects 4
Anxiety
36.8%
70%
Jaw Clenching
36.8%
70%
Headache
31.6%
70%
Nausea
26.3%
70%
Dosage Distribution
Dose distribution from experience reports
Median: 75.0 mg
IQR: 50.0–100.0 mg
n=11
Common Combinations
Most co-occurring substances in experience reports
Form / Preparation
Most common forms and preparations reported
Body-Weight Dosing
Dose relative to body weight from reports with weight data
Median: 0.973 mg/kg
IQR: 0.735–1.073 mg/kg
n=10
Redose Patterns
Redosing behavior across 13 reports
30.8%
Redosed
1.3
Avg Doses